Insider · CIK 0001924797

Ray Amrit

Reports to the SEC for 2 companies · DURHAM, NC

sec.gov

Transactions

Companies

Filings

CIK

0001924797

Forms 4 and 5

Insider transactions

22 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-10	FTREFortrea Holdings Inc.M Exercise/Conversion	Director	MExercise/Conversion	+38.8K sh	—	—	52,453
2026-06-10	FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−38.8K sh	—	—	0
2026-06-10	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+12.9K sh	—	—	12,852
2026-05-14	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+7,751 sh	—	—	31,116
2026-05-14	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+14.1K sh	—	—	14,058
2025-06-10	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+38.8K sh	—	—	38,817
2025-05-15	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,740 sh	—	—	23,365
2025-05-15	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.8K sh	—	—	10,787
2025-05-14	FTREFortrea Holdings Inc.M Exercise/Conversion	Director	MExercise/Conversion	+7,282 sh	—	—	13,636
2025-05-14	FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−7,282 sh	—	—	0
2024-07-18	FTREFortrea Holdings Inc.M Exercise/Conversion	Director	MExercise/Conversion	+6,354 sh	—	—	6,354
2024-07-18	FTREFortrea Holdings Inc. · Restricted Stock UnitM Exercise/Conversion	Director	MExercise/Conversion	−6,354 sh	—	—	7,282
2024-06-18	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,345 sh	—	—	17,625
2024-06-18	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,900 sh	—	—	9,900
2024-05-14	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+7,282 sh	—	—	13,636
2023-07-18	FTREFortrea Holdings Inc. · Restricted Stock UnitA Award	Director	AAward	+6,354 sh	—	—	6,354
2023-06-07	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,860 sh	—	—	12,280
2023-06-07	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,110 sh	—	—	7,110
2022-06-24	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+3,300 sh	—	—	8,420
2022-06-24	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+6,245 sh	—	—	6,245
2022-04-19	RAREUltragenyx Pharmaceutical Inc.A Award	Director	AAward	+5,120 sh	—	—	5,120
2022-04-19	RAREUltragenyx Pharmaceutical Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,525 sh	—	—	9,525

Recent filings

Accepted (ET)
Jun 124
Ray Amrit0001965040-26-000081
SEC(opens sec.gov)
May 184
Ray Amrit0001924797-26-000002
SEC(opens sec.gov)
Jun 124
Ray Amrit0001127602-25-017401
SEC(opens sec.gov)
May 194
Ray Amrit0000950170-25-074661
SEC(opens sec.gov)
May 164
Ray Amrit0001127602-25-014739
SEC(opens sec.gov)
Jul 194
Ray Amrit0001127602-24-020748
SEC(opens sec.gov)
Jun 204
Ray Amrit0000950170-24-075486
SEC(opens sec.gov)
May 164
Ray Amrit0001127602-24-015694
SEC(opens sec.gov)
Jul 194
Ray Amrit0001127602-23-021034
SEC(opens sec.gov)
Jun 94
Ray Amrit0001209191-23-035692
SEC(opens sec.gov)
Jun 284
Ray Amrit0001209191-22-039564
SEC(opens sec.gov)

Companies

Address

8 MOORE DRIVE

DURHAM, NC, 27713